![Peter Schiff Has Some Bad News for Bitcoin ETF Investors](https://i-invdn-com.investing.com/news/LYNXMPEE0502N_S.jpg)
Please try another search
Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan. The company provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products. It also offers IT service related to healthcare; and disease risk testing services. In addition, the company is involved with research and development of diagnostic drugs; and planning, development and OEM manufacturing of health food, pharmaceuticals, general food and other products. The company was founded in 1951 and is headquartered in Osaka, Japan.
Name | Age | Since | Title |
---|---|---|---|
Itsuro Yoshida | 71 | 1983 | President & Representative Director |
Kenichi Inoue | - | 2023 | Director |
Masao Tanaka | 70 | 2017 | Director |
Norikazu Eiki | 76 | 2015 | Independent Outside Director |
Kenryo Goto | 66 | 2021 | Independent Outside Director |
Toshikazu Kokubun | - | 2024 | Director |
Kaori Oishi | 47 | 2020 | Independent Outside Director |
Osamu Uchikawa | - | 2018 | Senior Operating Officer & Director |
Nobuki Ando | 70 | 2024 | Independent Outside Director |
Masaaki Takeyasu | 60 | 2024 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review